Taking peopleNo phase
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Luebeck
- Trial code
- NCT06493994
- Record updated
- 3 January 2025
- Original description
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).Read full original descriptionShow less
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Inclusion: Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement; BMI <35 kg/m2; Ability to give informed consent.
Exclusion: History of coronary artery bypass graft and a patent left internal mammary artery (LIMA); Age ≤18 years; Expected life expectancy <2 years; Patients presenting with pregnancy; Patients without informed consent.